R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Associate Director - Market Access AMNOG

Growth & MarketingConfirmed live in the last 24 hours
Full-timeMunich, GermanyNo salary listed

About the Job

Requirements

  • An advanced degree, such as a PhD in Life Sciences, Pharmacy, Health Economics, or Public Health.
  • At least 8 years of experience in market access, pricing, reimbursement, or health economics in pharma, biotech, or market access consulting.
  • Proven AMNOG or benefit-assessment experience and a deep understanding of payer decision-making in Germany.
  • Demonstrated experience supporting an oncology product pre-launch, launch, and post-launch in Germany.
  • Demonstrated success negotiating pricing and reimbursement conditions with public administrations and health authorities.
  • Strong stakeholder management and ability to collaborate with internal and external partners.
  • Ability to communicate effectively in person and virtually.
  • A scientific, solution-oriented mindset and the ability to execute in a rapidly changing, ambiguous environment.
  • Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments.
  • Strong commercial and strategic acumen.
  • Willingness to travel nationally and internationally.
  • Proven leadership and people-management capabilities, with success in a small but fast-growing entrepreneurial commercial environment.

Responsibilities

  • Develop and implement strategies to support access and pricing decisions for oncology products within the German healthcare system.
  • Lead preparation and submission of value dossiers and benefit assessments, including AMNOG/G-BA submissions, and lead pricing negotiations with statutory health insurance decision-makers such as GKV-SV.
  • Translate clinical and economic evidence into value communications tailored for German payers.
  • Build and maintain relationships with external stakeholders, including payers, HTA authorities, and policy influencers.
  • Work with Global and EU Region Market Access teams to align local access strategy with broader European and corporate objectives, including alignment of European regulatory and JCA strategy and execution with local value dossier submissions and pricing negotiation strategies.
  • Participate in negotiations with all levels of national payers.
  • Collaborate with internal functions to develop innovative pricing and value-based contracting models to accelerate reimbursement approvals.
  • Monitor health policy developments, HTA processes, and local reimbursement environments to inform strategy.
  • Drive access- and value-related projects, including landscape assessments, payer market research, payer advisory boards, and guidance on local strategies.
  • Develop outreach and engagement plans for key payers and their influencers, creating and maintaining a strong network.
  • Participate in early access planning for new products and indications, and drive launch readiness for multiple oncology assets.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs